NCT03167216View on ClinicalTrials.gov

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

April 1, 2022

Study Completion Date

June 30, 2022

Conditions
Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions
DRUG

Cromolyn Sodium

Mast cell stabilizer

DRUG

Cetirizine Hydrochloride

Histamine receptor antagonist

Trial Locations (1)

60611

Northwestern Medical Faculty Foundation, Chicago

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Northwestern University

OTHER

NCT03167216 - Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction | Biotech Hunter | Biotech Hunter